Brain Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Cancer, including details on symptoms, benign and malignant tumors, gliomas, treatment.

Volume 4 (2007), Issue 4 (April)

1. Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function.
   J Clin Oncol, 25(10): 1260-6. [Abstract] [Full-text]
2. Molecular profiling identifies prognostic subgroups of pediatric glioblastoma and shows increased YB-1 expression in tumors.
   J Clin Oncol, 25(10): 1196-208. [Abstract] [Full-text]
3. Pituitary adenoma, craniopharyngioma, and Rathke cleft cyst involving both intrasellar and suprasellar regions: differentiation using MRI.
   Clin Radiol, 62(5): 453-62. [Abstract] [Full-text]
4. Assessment of the morphological and functional effects of the anti-angiogenic agent SU11657 on 9L gliosarcoma vasculature using dynamic susceptibility contrast MRI.
   Magn Reson Med, 57(4): 680-7. [Abstract] [Full-text]
5. Magnetic resonance spectroscopy suggests key differences in the metastatic behaviour of medulloblastoma.
   Eur J Cancer, 43(6): 1037-44. [Abstract] [Full-text]
6. Upregulation of the WNT pathway in tuberous sclerosis-associated subependymal giant cell astrocytomas.
   Brain Dev, 29(5): 273-80. [Abstract] [Full-text]
7. Optimization of megavoltage CT scan registration settings for brain cancer treatments on tomotherapy.
   Phys Med Biol, 52(8): N185-93. [Abstract] [Full-text]
8. Transfection with anti-p65 intrabody suppresses invasion and angiogenesis in glioma cells by blocking nuclear factor-kappaB transcriptional activity.
   Clin Cancer Res, 13(7): 2178-90. [Abstract] [Full-text]
9. Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4+ T cell compartment without affecting regulatory T-cell function.
   Clin Cancer Res, 13(7): 2158-67. [Abstract] [Full-text]
10. Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment.
    Clin Cancer Res, 13(7): 2038-45. [Abstract] [Full-text]
11. Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).
    Br J Cancer, 96(7): 1047-51. [Abstract] [Full-text]
12. Identification of genomic aberrations associated with shorter overall survival in patients with oligodendroglial tumors.
    Int J Cancer, 120(11): 2368-76. [Abstract] [Full-text]
13. Effect of human skin-derived stem cells on vessel architecture, tumor growth, and tumor invasion in brain tumor animal models.
    Cancer Res, 67(7): 3054-63. [Abstract] [Full-text]
14. Tumor-specific cooperation of retinoblastoma protein family and Snf5 inactivation.
    Cancer Res, 67(7): 3002-9. [Abstract] [Full-text]
15. Optically neuronavigated ultrasonography in an intraoperative magnetic resonance imaging environment.
    Neurosurgery, 60(4): 373-80; discussion 380-1. [Abstract] [Full-text]
16. A novel, inexpensive method of image coregistration for applications in image-guided surgery using augmented reality.
    Neurosurgery, 60(4): 366-71; discussion 371-2. [Abstract] [Full-text]
17. Combined x-ray and magnetic resonance imaging facility: application to image-guided stereotactic and functional neurosurgery.
    Neurosurgery, 60(4): 352-60; discussion 360-1. [Abstract] [Full-text]
18. Angled screw holes for anterior posts and a frame-positioning device for gamma knife radiosurgery: allowing for better targeting of intracranial lesions.
    Neurosurgery, 60(4): 339-43; discussion 343-4. [Abstract] [Full-text]
19. Neuronavigation without rigid pin fixation of the head in left frontotemporal tumor surgery with intraoperative speech mapping.
    Neurosurgery, 60(4): 330-8; discussion 338. [Abstract] [Full-text]
20. Avoidance of carotid artery injuries in transsphenoidal surgery with the Doppler probe and micro-hook blades.
    Neurosurgery, 60(4): 322-8; discussion 328-9. [Abstract] [Full-text]
21. Graded repair of cranial base defects and cerebrospinal fluid leaks in transsphenoidal surgery.
    Neurosurgery, 60(4): 295-303; discussion 303-4. [Abstract] [Full-text]
22. Microsurgical technique and results of a series of 63 spheno-orbital meningiomas.
    Neurosurgery, 60(4): 214-21; discussion 221-2. [Abstract] [Full-text]
23. Endoscopic endonasal resection of a synchronous pituitary adenoma and a tuberculum sellae meningioma: technical case report.
    Neurosurgery, 60(4): E401; discussion E401. [Abstract] [Full-text]
24. Solitary fibrous tumors of the central nervous system: clinicopathological and therapeutic considerations of 18 cases.
    Neurosurgery, 60(4): 715-22; discussion 722. [Abstract] [Full-text]
25. Clinical significance of ABCA2' a possible molecular marker for oligodendrogliomas.
    Neurosurgery, 60(4): 707-14; discussion 714. [Abstract] [Full-text]
26. Response of C-reactive protein after craniotomy for microsurgery of intracranial tumors.
    Neurosurgery, 60(4): 621-5; discussion 625. [Abstract] [Full-text]
27. The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot study.
    Neurosurgery, 60(4): 601-11; discussion 611-2. [Abstract] [Full-text]
28. Extracranial nasopharyngeal craniopharyngioma: case report.
    Neurosurgery, 60(4): E780-1; discussion E781. [Abstract] [Full-text]
29. Lymphangioma of the clivus: case report.
    Neurosurgery, 60(4): E779; discussion E779. [Abstract] [Full-text]
30. Chronic subdural hematoma associated with subdural rhabdomyosarcoma: case report.
    Neurosurgery, 60(4): E774-5; discussion E775. [Abstract] [Full-text]
31. Secondary glioblastoma multiforme after treatment for primary choroid plexus carcinoma in childhood.
    J Pediatr Hematol Oncol, 29(4): 248-52. [Abstract] [Full-text]
32. Cellular and functional characterization of immunoresistant human glioma cell clones selected with alloreactive cytotoxic T lymphocytes reveals their up-regulated synthesis of biologically active TGF-beta.
    J Immunother (1997), 30(3): 261-73. [Abstract] [Full-text]
33. Contribution of F-18 FDG PET-CT in the detection of systemic spread of primary central nervous system lymphoma.
    Clin Nucl Med, 32(4): 271-4. [Abstract] [Full-text]
34. Glioma risk in relation to serum levels of insulin-like growth factors.
    Cancer Epidemiol Biomarkers Prev, 16(4): 844-6. [Abstract] [Full-text]
35. Expression and structure of interleukin 4 receptor (IL-4R) complex in human invasive pituitary adenomas.
    Neurosci Lett, 417(1): 30-5. [Abstract] [Full-text]
36. Differential effects of PPARgamma agonists on the metabolic properties of gliomas and astrocytes.
    Neurosci Lett, 417(1): 72-7. [Abstract] [Full-text]
37. Cross-priming by temozolomide enhances antitumor immunity of dendritic cell vaccination in murine brain tumor model.
    Vaccine, 25(17): 3485-91. [Abstract] [Full-text]
38. What is the best adjuvant treatment for very young patients with medulloblastoma?
    Expert Rev Neurother, 7(4): 373-81. [Abstract] [Full-text]
39. Use of nanoparticles for drug delivery in glioblastoma multiforme.
    Expert Rev Neurother, 7(4): 363-72. [Abstract] [Full-text]
40. Psychiatric manifestations of brain tumors: diagnostic implications.
    Expert Rev Neurother, 7(4): 343-9. [Abstract] [Full-text]
41. Direct vaccination with pseudotype baculovirus expressing murine telomerase induces anti-tumor immunity comparable with RNA-electroporated dendritic cells in a murine glioma model.
    Cancer Lett, 250(2): 276-83. [Abstract] [Full-text]
42. Radiotherapy for glioblastoma in the elderly.
    N Engl J Med, 356(15): 1527-35. [Abstract] [Full-text]
43. ECT in patients with intracranial masses.
    J Neuropsychiatry Clin Neurosci, 19(2): 191-3. [Abstract] [Full-text]
44. Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management.
    Lancet Neurol, 6(5): 421-30. [Abstract] [Full-text]
45. Arsenic-induced APL differentiation in cerebrospinal fluid.
    Leuk Res, 31(5): 703-5. [Abstract] [Full-text]
46. Intracranial dissemination of primary spinal cord anaplastic oligodendroglioma.
    Eur J Neurol, 14(5): 578-80. [Abstract] [Full-text]
47. Gelatinolytic activity of matrix metalloproteinase-2 and matrix metalloproteinase-9 in rat brain after implantation of 9L rat glioma cells.
    Eur J Neurol, 14(5): 510-6. [Abstract] [Full-text]
48. Differential cellular gene expression in ganglioglioma.
    Epilepsia, 48(4): 646-53. [Abstract] [Full-text]
49. Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy.
    Br J Cancer, 96(8): 1293-301. [Abstract] [Full-text]
50. Genetic variation in p53 and ATM haplotypes and risk of glioma and meningioma.
    J Neurooncol, 82(3): 229-37. [Abstract] [Full-text]
51. Single nucleotide polymorphisms and expression of ERCC1 and ERCC2 vis-à-vis chemotherapy drug cytotoxicity in human glioma.
    J Neurooncol, 82(3): 257-62. [Abstract] [Full-text]
52. Impact of novel PTEN mutations in Turkish patients with glioblastoma multiforme.
    J Neurooncol, 82(3): 263-9. [Abstract] [Full-text]
53. Fractionated stereotactic radiotherapy using gamma unit after hyperbaric oxygenation on recurrent high-grade gliomas.
    J Neurooncol, 82(3): 297-303. [Abstract] [Full-text]
54. Differentiation of recurrent astrocytoma from radiation necrosis: a pilot study with 13N-NH3 PET.
    J Neurooncol, 82(3): 305-11. [Abstract] [Full-text]
55. Toxicity and efficacy of protracted low dose temozolomide for the treatment of low grade gliomas.
    J Neurooncol, 82(3): 281-8. [Abstract] [Full-text]
56. The 1p-encoded protein stathmin and resistance of malignant gliomas to nitrosoureas.
    J Natl Cancer Inst, 99(8): 639-52. [Abstract] [Full-text]
57. Acidic triterpenes compromise growth and survival of astrocytoma cell lines by regulating reactive oxygen species accumulation.
    Cancer Res, 67(8): 3741-51. [Abstract] [Full-text]
58. Huntingtin interacting protein 1 is a novel brain tumor marker that associates with epidermal growth factor receptor.
    Cancer Res, 67(8): 3609-15. [Abstract] [Full-text]
59. Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors.
    Cancer Res, 67(8): 3560-4. [Abstract] [Full-text]
60. Correlation between O6-methylguanine-DNA methyltransferase and survival in inoperable newly diagnosed glioblastoma patients treated with neoadjuvant temozolomide.
    J Clin Oncol, 25(12): 1470-5. [Abstract] [Full-text]
61. Neuroimaging characteristics in subgroup of GBMs with p53 overexpression.
    J Neuroimaging, 17(2): 168-74. [Abstract] [Full-text]
62. Images in neuro oncology: primary extraaxial cerebellopontine angle ependymoma.
    J Neurooncol, 83(1): 31-2. [Abstract] [Full-text]
63. Metastasis of a histologically benign choroid plexus papilloma: case report and review of the literature.
    J Neurooncol, 83(1): 47-52. [Abstract] [Full-text]
64. Expression pattern of the water channel aquaporin-4 in human gliomas is associated with blood-brain barrier disturbance but not with patient survival.
    J Neurosci Res, 85(6): 1336-46. [Abstract] [Full-text]
65. Long-term outcome of patients with intracranial germinoma.
    J Neurooncol, 83(1): 71-9. [Abstract] [Full-text]
66. Frequent but borderline methylation of p16 (INK4a) and TIMP3 in medulloblastoma and sPNET revealed by quantitative analyses.
    J Neurooncol, 83(1): 17-29. [Abstract] [Full-text]
67. Convection enhanced delivery for treating brain tumors and selected neurological disorders: symposium review.
    J Neurooncol, 83(1): 97-109. [Abstract] [Full-text]
68. Gliosarcoma with multiple extracranial metastases: case report and review of the literature.
    J Neurooncol, 83(1): 39-46. [Abstract] [Full-text]
69. Adrenal insufficiency secondary to glucocorticoid withdrawal in patients with brain tumor.
    Surg Neurol, 67(5): 508-10. [Abstract] [Full-text]
70. Evaluation of an anaesthetic technique used in dogs undergoing craniectomy for tumour resection.
    Vet Anaesth Analg, 34(3): 171-80. [Abstract] [Full-text]
71. Preferred transport of O-(2-[18F]fluoroethyl)-D-tyrosine (D-FET) into the porcine brain.
    Brain Res, 1147: 25-33. [Abstract] [Full-text]
72. Roles of sphingosine-1-phosphate (S1P) receptors in malignant behavior of glioma cells. Differential effects of S1P2 on cell migration and invasiveness.
    Exp Cell Res, 313(8): 1615-27. [Abstract] [Full-text]
73. GliaSite brachytherapy boost as part of initial treatment of glioblastoma multiforme: a retrospective multi-institutional pilot study.
    Int J Radiat Oncol Biol Phys, 68(1): 159-65. [Abstract] [Full-text]
74. Evaluation of peritumoral edema in the delineation of radiotherapy clinical target volumes for glioblastoma.
    Int J Radiat Oncol Biol Phys, 68(1): 144-50. [Abstract] [Full-text]
75. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
    Int J Radiat Oncol Biol Phys, 68(1): 151-8. [Abstract] [Full-text]
76. Magnetic resonance elastography of brain tumors: preliminary results.
    Acta Radiol, 48(3): 327-30. [Abstract] [Full-text]
77. Reduction of high-affinity beta2-adrenergic receptor binding by hyperforin and hyperoside on rat C6 glioblastoma cells measured by fluorescence correlation spectroscopy.
    Biochemistry, 46(17): 5106-13. [Abstract] [Full-text]
78. Nitric oxide donors attenuate clongenic potential in rat C6 glioma cells treated with alkylating chemotherapeutic agents.
    Neurosci Lett, 418(1): 106-10. [Abstract] [Full-text]
79. Iris cavernous hemangioma associated with multiple cavernous hemangiomas in the kidney, brain, and skin.
    Cornea, 26(4): 481-3. [Abstract] [Full-text]
80. Intraaxial brain masses: MR imaging-based diagnostic strategy--initial experience.
    Radiology, 243(2): 539-50. [Abstract] [Full-text]
81. Epigenetic silencing through DNA and histone methylation of fibroblast growth factor receptor 2 in neoplastic pituitary cells.
    Am J Pathol, 170(5): 1618-28. [Abstract] [Full-text]
82. Genetic pathways to primary and secondary glioblastoma.
    Am J Pathol, 170(5): 1445-53. [Abstract] [Full-text]
83. Malignant supratentorial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitative diffusion-weighted MR imaging.
    Radiology, 243(2): 493-9. [Abstract] [Full-text]
84. Systematic review of the diagnostic accuracy of 201Tl single photon emission computed tomography in the detection of recurrent glioma.
    Nucl Med Commun, 28(6): 431-9. [Abstract] [Full-text]
85. Papillary tumors of the pineal region: case report.
    Neurosurgery, 60(5): E953-5; discussion E953-5. [Abstract] [Full-text]
86. Caveolin-1 expression is variably displayed in astroglial-derived tumors and absent in oligodendrogliomas: concrete premises for a new reliable diagnostic marker in gliomas.
    Am J Surg Pathol, 31(5): 760-9. [Abstract] [Full-text]
87. Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification.
    Nat Clin Pract Oncol, 4(5): 295-304. [Abstract] [Full-text]
88. Signaling pathways involved in antioxidant control of glioma cell proliferation.
    Free Radic Biol Med, 42(11): 1715-22. [Abstract] [Full-text]
89. Towards hyperpolarized (13)C-succinate imaging of brain cancer.
    J Magn Reson, 186(1): 150-5. [Abstract] [Full-text]
90. Simultaneous detection of resolved glutamate, glutamine, and gamma-aminobutyric acid at 4 T.
    J Magn Reson, 185(2): 204-13. [Abstract] [Full-text]

© 2004-2012 Brain Cancer Research Today. All Rights Reserved.